Bionano Genomics (NASDAQ: BNGO)
Bionano Genomics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bionano Genomics Company Info
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
News & Analysis
Why Bionano Genomics Stock Tanked Today
A CFO departure shines a light on some of the company's recent struggles.
Why Shares of Bionano Genomics Are Up Monday
The life sciences company said it expects another improved quarter of revenue.
Buy This Magnificent Growth Stock Before It's Too Late
Bionano is gaining momentum and could soon be approaching escape velocity.
Is Bionano Genomics Stock a Buy Now?
Revenue growth is likely on the way, but the stock price doesn't reflect that potential.
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over Fist
With no recent stumbles and more growth on the way, buying shares now could be a smart move.
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
These cutting-edge biotech companies quickly fell out of favor with investors this week.
This Innovative Growth Stock Could Double or More in 2023
Investors have high expectations for Bionano Genomics, but they might not pan out.
2 Penny Stocks That Could Make You Filthy Rich
These low-priced equities could explode higher soon.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.